ERBB2 and breast carcinoma: Although ligstroside aglycone has been shown to have moderate in vitro cytotoxicity against a panel of 39 human cancer cell lines [136], Mendez et al. reported that ligstroside aglycone induced apoptosis in breast cancer cells overexpressing HER2 [129].